Skip to content

Study on the involvement of gastrointestinal microflora in the pathogenesis of pancreatic cancer

Study on the involvement of gastrointestinal microflora in the pathogenesis of pancreatic cancer

Status
Recruiting
Phases
Early Phase 1
Study type
Observational
Source
ChiCTR
Registry ID
ChiCTR2200055716
Enrollment
Unknown
Registered
2022-01-16
Start date
2022-01-30
Completion date
Unknown
Last updated
2023-06-26

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Pancreatic cancer

Interventions

According to the pathological results, they were divided into experimental group and control group. Experimental group: endoscopic ultrasound fine needle aspiration pathological examination results we

Sponsors

Department of Gastroenterology, Qilu Hospital, Cheloo College of Medicine, Shandong University
Lead Sponsor

Eligibility

Sex/Gender
All
Age
18 Years to No maximum

Inclusion criteria

Inclusion criteria: 1. Aged 18 years and over; 2. Written informed consent obtained; 3. For patients with pancreatic lesions, including benign lesions such as pancreatic cyst, pancreatitis or pancreatic cancer, Endoscopic ultrasound (EUS) is required, and biopsy tissue is required to further confirm the diagnosis.

Exclusion criteria

Exclusion criteria: 1. Patients with pancreatic lesions considered as clinical diagnosis, who need Endoscopic ultrasound (EUS) to be clear, but refuse further examination; 2. Patients whose clinical diagnosis considered pancreatic lesions, but the condition did not allow further invasive surgical examination.

Design outcomes

Primary

MeasureTime frame
Microbiota;Clinical indicators (symptoms, signs, examinations,laboratory indicators);

Countries

China

Contacts

Public ContactLi Zhen

Department of Gastroenterology, Qilu Hospital, Cheloo College of Medicine, Shandong University

lizhenh@hotmail.com+86 18560086106

Outcome results

None listed

Source: ChiCTR (via WHO ICTRP) · Data processed: Feb 4, 2026